Pharmacological characterization of muscarinic receptors in the uterus of oestrogen-primed and pregnant rats
- 1 April 1998
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 123 (8) , 1639-1644
- https://doi.org/10.1038/sj.bjp.0701794
Abstract
1. Radioligand binding and contractility studies were undertaken to determine the subtype/s of muscarinic receptors present in uteri of oestrogen-treated and late pregnant rats. 2. Competition binding studies with uterine membrane preparations and [3H]-QNB (quinuclidinyl benzilate) provided negative log dissociation constants (pKi) for each antagonist as follows; oestrogen-treated - atropine (7.98) > or = himbacine (7.83) > methoctramine (7.52) > or = hexahydrosiladiphenidol (HHSiD; 7.32) > or = 5,11-dihydro- 11-[[[2-[2 - [(dipropylamino)methyl] - 1 piperidinyl]ethyl]amino] - carbonyl] - 6H-pyrido-[2,3-b][1,4]- benzodiazepin-6-one (AF-DX 384; 7.10)> 11 -[[2- [(diethylamino)methyl]-1-piperidinyl]-acetyl]5,11-dihydro-6H-pyridol+ ++]2,3,-b][1,4]benzodiazepin-6-one (AF-DX 116, 6.77)>pirenzepine (6.17); late pregnant atropine (8.05)> or =methoctramine (7.95)> or =himbacine (7.71)> or =HHSiD (7.52)> or =AF-DX 384 (7.34)>AF-DX 116 (6.72)>pirenzepine (6.18). 3. The potency of carbachol in causing uterine contraction was similar in preparations from pregnant and non-pregnant animals (pD2=5.57 and 5.46, respectively). Each muscarinic antagonist caused parallel, rightward shifts of carbachol concentration-response curves. The pA2 estimates were: oestrogen-treated - atropine (9.42)> himbacine (8.73) HHSiD (8.68) methoctramine (8.49)> or =AF-DX 384 (7.91)> or =AF-DX 116 (7.36)> or =pirenzepine (7.26); late pregnant atropine (9.48)>himbacine (8.37)> or = HHSiD (8.22) > or =methoctramine (8.01) > or =AF-DX 116 (7.73)> or = AF-DX 384 (7.44)> or = pirenzepine (6.92). 4. The relative pKi estimates for antagonists obtained in membrane preparations from oestrogen-treated rats suggest the presence of muscarinic M2 subtypes. In functional studies pA2 values indicated the additional presence of muscarinic M3 receptor or, possibly an atypical receptor subtype. The similarity between pKi and pA2 estimates obtained in uteri from oestrogen-treated and pregnant animals, respectively, indicates that pregnancy does not affect myometrial muscarinic receptors in the rat.Keywords
This publication has 14 references indexed in Scilit:
- Selective Muscarinic Receptor Agonists and AntagonistsBasic & Clinical Pharmacology & Toxicology, 1996
- Muscarinic receptors in rat uterusEuropean Journal of Pharmacology, 1994
- Muscarinic acetylcholine receptor subtypes in smooth muscleTrends in Pharmacological Sciences, 1994
- Characterization of muscarinic receptors in guinea-pig uterusEuropean Journal of Pharmacology, 1993
- Muscarinic Receptors—Characterization, coupling and functionPharmacology & Therapeutics, 1993
- Mechanical Responses of the Rat Uterus, Cervix, and Bladder to Stimulation of Hypogastric and Pelvic Nerves in Vivo1Biology of Reproduction, 1989
- Analysis of radioligand binding experimentsJournal of Pharmacological Methods, 1985
- Muscarinic cholonoceptors in the rabbits myometrium: A study of the relationship between binding and responseEuropean Journal of Pharmacology, 1984
- A simplified method for the quantitative assay of small amounts of protein in biologic materialAnalytical Biochemistry, 1973
- CHOLINERGIC MECHANISMS IN THE HUMAN UTERUSBJOG: An International Journal of Obstetrics and Gynaecology, 1971